Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
65 /100
HIGH RISK
Score updated Oct 13, 2026

NRSN — NeuroSense Therapeutics Ltd. Dilution Risk Tracker

Track NRSN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NRSN — Get alerts when the score changes →

As of October 13, 2026, NeuroSense Therapeutics Ltd. (NRSN) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. NeuroSense Therapeutics Ltd. has a market capitalization of $113.30M, 32.56M shares outstanding, 14 institutional holders tracked. Stored dilution-related fields include 2.98M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
95
📊 Float Risk
27
⚠️ Warrant Exposure
30
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 54%
🔄 Reverse Split model est. 70%
• 50-day avg $0.79 below $1 exchange minimum
• Only 0 months cash — financial pressure
💰 Capital Raise model 55%
• Critical: only 0.2 months cash remaining
📜 Warrant Exercise model 15%
• Warrant overhang: 9.2% of shares outstanding
🔔 Track NRSN — Get forecast alerts →

Market Data

Market Cap$113.30M
Shares Outstanding32.56M
Float24.95M
Cash$166.0K
Debt$170.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore65/100DilutionWatch score record
Shares Outstanding32.56MVerified float table or market cache
Public Float24.95MVerified float table or market cache
Market Cap$113.30MMarket data cache
Cash Runway0.2 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants2.98MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 28.9% shares (2026Q1 vs prior)
14 institutional holders · 446.1K shares
#1 Yorkville Advisors Global, LP 78.0K shares
#2 MORGAN STANLEY 66.4K shares
#3 Independent Advisor Alliance 50.0K shares
+ 11 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest26.9K
Days to Cover1.2
% of Float0.1%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-31
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual NRSN Dilution Snapshot

NeuroSense Therapeutics Ltd. (NRSN) has a DilutionScore of 65/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

NRSN's DilutionScore is currently 65/100 (High risk), with 2 score changes tracked over 89 days. The score deteriorated from 77/100 (Critical risk).

Period Score Risk Level Duration
Aug 14 – Oct 13, 202665/100HIGH60 days
Jul 17 – Aug 13, 202677/100CRITICAL28 days
Jul 16, 202676/100CRITICAL1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

NRSN shares outstanding have increased 8.1% from 33.40M (Mar 2026) to 36.10M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 30, 202636.10M24.95M▼ 0.80%
May 29, 202636.10M25.15M▼ 3.38%
Apr 23, 202635.35M26.03M▼ 0.70%
Apr 07, 202633.40M26.21M▲ 0.54%
Apr 03, 202633.40M26.07M▲ 61.86%
Mar 28, 202633.40M16.11M▼ 1.08%
Mar 22, 202633.40M16.28M▼ 1.28%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track NRSN Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment NRSN files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking NRSN — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for NRSN
NRSN FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.